Cargando…
Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
Since December 2019, the infection of the new coronavirus (COVID-19) caused an outbreak of new coronavirus pneumonia in Wuhan, China, and caused great public concern. Both COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through ACE2. An in-depth understanding of A...
Autores principales: | Li, Shu-ren, Tang, Zi-jian, Li, Zai-han, Liu, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152693/ https://www.ncbi.nlm.nih.gov/pubmed/32285293 http://dx.doi.org/10.1007/s10096-020-03883-y |
Ejemplares similares
-
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
por: Li, Wenhui, et al.
Publicado: (2003) -
Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013) -
The Cell Biology of the SARS Coronavirus Receptor, Angiotensin-Converting Enzyme 2
por: Lambert, Daniel W.
Publicado: (2009) -
The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19
por: Oyagbemi, Ademola Adetokunbo, et al.
Publicado: (2021)